Literature DB >> 7935860

Effect of norathyriol, isolated from Tripterospermum lanceolatum, on A23187-induced pleurisy and analgesia in mice.

J P Wang1, T F Ho, C N Lin, C M Teng.   

Abstract

A23187-induced pleurisy in the mouse was demonstrated in this study. The protein leakage, leukocyte accumulation, LTB4 and PGE2 production in the pleural cavity of mice were increased by A23187 in a dose-dependent manner. At 7.5 nmole A23187 intrapleural injection, the protein level peaked at 0.5-2 h, PMN leukocytes accumulation peaked at 3-4 h, and LTB4 and PGE2 production peaked at 0.5-1 h. In this in vivo model we investigated the anti-inflammatory effect of norathyriol, isolated from Tripterospermum lanceolatum. A23187-induced protein leakage was reduced by norathyriol (ID50 was about 30.6 mg/kg i.p.), indomethacin and BW755C. A23187-induced PMN leukocytes accumulation was suppressed by norathyriol (ID50 was about 16.8 mg/kg, i.p.) and BW755C, while enhanced by indomethacin. Like BW755C, norathyriol reduced both LTB4 and PGE2 production (ID50 was about 18.6 and 29.1 mg/kg i.p., respectively), while indomethacin reduced PGE2 but not LTB4 generation. We also demonstrated the analgesic effect of norathyriol on the acetic acid-induced writhing response. Acetic acid-induced writhing response was depressed by norathyriol (ID50 was about 27.9 mg/kg i.p.), indomethacin and ibuprofen. These results suggest that norathyriol, like BW755C, might be a dual, yet weak, cyclooxygenase and lipoxygenase pathway blocker. The inhibitory effect of norathyriol on the A23187-induced pleurisy and acetic acid-induced writhing response in mice is proposed to be dependent on the reduction of eicosanoids mediators formation in the inflammatory site.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7935860     DOI: 10.1007/bf00180016

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  24 in total

1.  A new approach to anti-inflammatory drugs.

Authors:  G A Higgs; R J Flower; J R Vane
Journal:  Biochem Pharmacol       Date:  1979-06-15       Impact factor: 5.858

2.  Tolfenamic acid inhibits leukotriene B4-induced chemotaxis of polymorphonuclear leukocytes in vitro.

Authors:  H Kankaanranta; E Moilanen; H Vapaatalo
Journal:  Inflammation       Date:  1991-04       Impact factor: 4.092

3.  Control of vascular permeability by polymorphonuclear leukocytes in inflammation.

Authors:  C V Wedmore; T J Williams
Journal:  Nature       Date:  1981-02-19       Impact factor: 49.962

4.  Possible role of arachidonic acid and its metabolites in mediator release from rat mast cells.

Authors:  T J Sullivan; C W Parker
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

Review 5.  The pharmacology and pathophysiology of leukotriene B4.

Authors:  M A Bray
Journal:  Br Med Bull       Date:  1983-07       Impact factor: 4.291

Review 6.  Eicosanoid production by the coronary microvascular endothelium.

Authors:  M E Gerritsen
Journal:  Fed Proc       Date:  1987-01

7.  Novel inhibitory actions on platelet thromboxane and inositolphosphate formation by xanthones and their glycosides.

Authors:  C M Teng; C N Lin; F N Ko; K L Cheng; T F Huang
Journal:  Biochem Pharmacol       Date:  1989-11-01       Impact factor: 5.858

8.  Calcium-phospholipid interactions in secretory cells: a new perspective on stimulus-secretion coupling.

Authors:  R P Rubin
Journal:  Fed Proc       Date:  1982-04

9.  Stimulation of endogenous prostacyclin protects the reperfused pig myocardium from ischemic injury.

Authors:  T Hohlfeld; H Strobach; K Schrör
Journal:  J Pharmacol Exp Ther       Date:  1993-01       Impact factor: 4.030

10.  Species difference in increased vascular permeability by synthetic leukotriene C4 and D4.

Authors:  A Ueno; K Tanaka; M Katori; M Hayashi; Y Arai
Journal:  Prostaglandins       Date:  1981-04
View more
  1 in total

1.  Inhibition of the arachidonic acid cascade by norathyriol via blockade of cyclooxygenase and lipoxygenase activity in neutrophils.

Authors:  Mei-Feng Hsu; Chun-Nan Lin; Min-Chi Lu; Jih-Pyang Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-04-09       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.